Official launch of the partnership between PPM and FAES Farma

Some 200 people attended on June 12 at Sokha Hotel the official launch of the commercial partnership between PPM Laboratories, Cambodia's leading pharmaceutical producer, and FAES Farma , a world-renowned Spanish pharmaceutical company. This collaboration marks an important milestone in PPM’s commitment to providing innovative, high-quality healthcare solutions to the Cambodian market.

The event was chaired by Dr. Hay Ly Eang, CEO of PPM, and Alberto Montero, Deputy International Director of FAES Farma with the participation of eminent healthcare professionals, pharmacists, distributors, etc.

Founded in 1933, Faes Farma has become in more than 90 years a global health entity known for its reliability, quality and innovation. FAES Farma is dedicated to research, production and marketing of pharmaceutical products and raw materials, and its products are present in 130 countries.

Distributed in Cambodia for around twenty years through products such as Dynamogen , Labixten , Ferroprotina , Potenciator and Positon, the Spanish laboratory has chosen to join forces with PPM to develop in the region.

“Our two pharmaceutical companies have the same profile in terms of experience and maturity. The painkiller Kinal, one of PPM's flagship products, was created in 1960 while FAES Farma has been a player in the pharmaceutical industry since years 1930. It is therefore normal that we join hands. In addition, we share the same vision of the development of our industry in terms of quality requirements, innovation and market approach. Finally, our product ranges are complementary. As Cambodia's leading medicine producer, dedicated to providing high-quality healthcare products and services, PPM is proud to contribute to improving the well-being of the Cambodian community through this business partnership with FAES Farma ” , emphasized Dr Hay Ly Eang,

Mr. Alberto Montero, representative of FAES Farma , indicated that for his company Cambodia was one of its priority markets as part of its expansion plans in Southeast Asia. “We strongly believe that PPM, as a leading local pharmaceutical company, with its commitment to quality and innovation, is the ideal partner for FAES,” he insisted.

This partnership is built around three key points: expanding the supply of high-quality medicines to the Cambodian population, combining FAES Farma's innovative research and development with PPM's extensive distribution network; improving access to health care; a strong contribution to the growth of the kingdom's economy by creating employment opportunities and promoting better health of the population.